The big wins have piled up recently for Winston & Strawn’s intellectual property team. In April, Winston’s James Hurst won a 9-0 ruling for client Caraco Pharmaceutical Laboratories Ltd. at the U.S. Supreme Court in a case that opens a new pathway for generic drug companies to challenge the accuracy of patent information name-brand companies give to the U.S. Food and Drug Administration. The defeat of Danish name-brand pharmaceutical firm Novo Nordisk A/S was just one of a string of wins for generic drug companies.
To view this content, please continue to Lexis Advance®.
Not a Lexis Advance® Subscriber? Subscribe Now
LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.
ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.
For questions call 1-877-256-2472 or contact us at email@example.com